Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects
Objective: The aim was to determine the epidemiologic, clinical and therapeutic aspects of patients treated for PD. Methods: This was a prospective and cross-sectional study…Prevalence of Parkinson’s disease in the region of Coquimbo, Chile
Objective: To determine the rate of prevalence of PD in the region of Coquimbo, Chile. Background: Parkinson's disease is a common neurodegenerative disease, second after…Non-contact boxing in Parkinson’s disease
Objective: To narratively review the effectiveness of non-contact boxing and explore its feasibility in individuals with Parkinson's disease (PD). Background: Complementary therapies have shown outcomes…Longitudinal assessment of caregiver strain in Parkinson’s disease
Objective: To examine changes in caregivers and predictors of increased caregiver strain in Parkinson's disease (PD). Background: Caregiver strain can increase with advanced PD. In…Quantifying turning behavior in Parkinson’s disease patients using mobile technology
Objective: To use inertial measurement unit (IMU) data from a mobile device, iPad or iPhone, to quantify PD patients' gait and turning behavior, on and…The role of non-steroidal anti-inflammatory use in symptomatic and asymptomatic LRRK2 G2019S mutation carriers
Objective: The purpose of the current study is to determine if non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of Parkinson's disease (PD) among LRRK2 G2019S…Longitudinal evaluation of motor and non motor symptoms among LRRK2 risk variants
Objective: To evaluate the clinical characteristics and progression of Parkinson's disease (PD) in patients with Asian-related LRRK2 variants, G2385R, R1628P and S1647T. Methods: A total…Differentiated versus undifferentiated mesenchymal stem cell therapy in paraquat model of Parkinson’s disease
Objective: To investigate the effect of undifferentiated versus differentiated CD34 stem cells series on paraquat model of PD and to elucidate the mechanism of action…Postural and nonmotor disturbances in Parkinson’s disease
Objective: To investigate postural impairments (PI) and their interrelation with non-motor symptoms in patients with Parkinson's disease (PD). Background: PI mechanisms are only partially known.…The epigenetic regulation of HIF-1α by SIRT1 in MPP+ treated SH-SY5Y cells
Objective: Both silent information regulator 1 (SIRT1) and hypoxia inducible factor 1 (HIF-1) have been found to play important roles in the pathophysiology of Parkinson's…
- « Previous Page
- 1
- …
- 395
- 396
- 397
- 398
- 399
- …
- 405
- Next Page »